Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron versus palonosetron for chemotherapy-induced nausea and vomiting in pediatric oncology
TCTR20261015005Phase 4Not yet recruiting
- Sponsor
- Dr Sahaf Ahmed
- Start
- Oct 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in chemotherapy-induced nausea and vomiting (CINV) comparing Ondansetron + dexamethasone with Palonosetron + dexamethasone (2 arms). Primary endpoints: Complete response, acute phase, Complete response, delayed phase and 1 more. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
ondansetronpalonosetrondexamethasone
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on TCTR20261015005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20261015005.